NASDAQ
DOMH

DOMH

Biotechnology
Healthcare

Prices are adjusted according to historical splits.

DOMH Stock Price

Vitals

Today's Low:
$2.7
Today's High:
$2.79
Open Price:
$2.79
52W Low:
$2.06
52W High:
$7.2673
Prev. Close:
$2.79
Volume:
5174

Company Statistics

Market Cap.:
$11.85 million
Book Value:
14.525
Revenue TTM:
$0
Operating Margin TTM:
0%
Gross Profit TTM:
$0
Profit Margin:
0%
Return on Assets TTM:
-9.16%
Return on Equity TTM:
-24%

Company Profile

DOMH had its IPO on 1984-09-07 under the ticker symbol DOMH.

The company operates in the Healthcare sector and Biotechnology industry. DOMH has a staff strength of 7 employees.

Stock update

Shares of DOMH opened at $2.79 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $2.7 - $2.79, and closed at $2.7.

This is a -3.23% slip from the previous day's closing price.

A total volume of 5,174 shares were traded at the close of the day’s session.

In the last one week, shares of DOMH have slipped by -1.1%.

DOMH's Key Ratios

DOMH has a market cap of $11.85 million, indicating a price to book ratio of 0 and a price to sales ratio of 0.

In the last 12-months DOMH’s revenue was $0 with a gross profit of $0 and an EBITDA of $0. The EBITDA ratio measures DOMH's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, DOMH’s operating margin was 0% while its return on assets stood at -9.16% with a return of equity of -24%.

In Q1, DOMH’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.

DOMH’s PE and PEG Ratio

Forward PE
0
Trailing PE
0
PEG

Its diluted EPS in the last 12-months stands at $-4.36 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into DOMH’s profitability.

DOMH stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of 0. Its price to sales ratio in the trailing 12-months stood at 0.

DOMH stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$74.15 million
Total Liabilities
$1.72 million
Operating Cash Flow
$0
Capital Expenditure
$361000
Dividend Payout Ratio
0%

DOMH ended 2024 with $74.15 million in total assets and $0 in total liabilities. Its intangible assets were valued at $74.15 million while shareholder equity stood at $69.07 million.

DOMH ended 2024 with $0 in deferred long-term liabilities, $1.72 million in other current liabilities, in common stock, $-189643000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $9.53 million and cash and short-term investments were $37.49 million. The company’s total short-term debt was $198,000 while long-term debt stood at $0.

DOMH’s total current assets stands at $44.77 million while long-term investments were $23.10 million and short-term investments were $27.96 million. Its net receivables were $6.54 million compared to accounts payable of $641000.00 and inventory worth $0.

In 2024, DOMH's operating cash flow was $0 while its capital expenditure stood at $361000.

Comparatively, DOMH paid $0 in dividends in 2024.

Other key metrics

Current Trading Price
$2.7
52-Week High
$7.2673
52-Week Low
$2.06
Analyst Target Price
$16

DOMH stock is currently trading at $2.7 per share. It touched a 52-week high of $7.2673 and a 52-week low of $7.2673. Analysts tracking the stock have a 12-month average target price of $16.

Its 50-day moving average was $2.92 and 200-day moving average was $3.29 The short ratio stood at 0.94 indicating a short percent outstanding of 0%.

Around 1625.3% of the company’s stock are held by insiders while 1285.3% are held by institutions.

Frequently Asked Questions About DOMH

The stock symbol (also called stock or share ticker) of DOMH is DOMH

The IPO of DOMH took place on 1984-09-07

Similar Industry Stocks (Biotechnology)

Last Price
Chg
Chg%
$13.33
0.04
+0.3%
$232.95
-19.1
-7.58%
$8.09
0.12
+1.51%
$1.33
-0.02
-1.48%
Birla Tyres Ltd (BIRLATYRES)
$5.24
-0.27
-4.9%
$1.3
0.09
+7.39%
$0.07
-0
-2.71%
$63.01
2.22
+3.65%
V2 Retail Limited (V2RETAIL)
$138.1
-5.25
-3.66%
$934.2
-114
-10.88%

Most Active

Last Price
Chg
Chg%
Amyris Inc (AMRS)
$0.14
0.07
+100%
$0.12
0.04
+45.29%
$0.96
0.05
+5.4%
$1.34
-0.35
-20.71%
Humbl Inc (HMBL)
$0
0
0%

Top Gainers

Last Price
Chg
Chg%
$0
0
+172200%
$0
0
+51200%
$283
280.03
+9428.62%
$11.2
10.57
+1667.68%
Latch Inc (LTCHW)
$0.01
-0.03
+1550%

Top Losers

Last Price
Chg
Chg%
$0.19
-123.15
-99.85%
$0
-0.11
-99.55%
$0
-0
-97.96%
$0
-0.01
-93.94%
$0.01
-0.06
-92.24%

About

Dominari Holdings Inc., a biotechnology company, focuses on developing small-molecule anticancer therapeutics. The company’s pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small molecule treatment for acute myeloid leukemia and acute lymphoblastic leukemia. The company is also developing an antiviral platform that inhibits replication of viruses, including influenza virus, Ebolavirus and Marburg virus, SARS-CoV, MERS-CoV, and SARS-CoV-2. It has license agreements with the University of Texas, Silo Pharma Inc., and Wake Forest University Health Sciences. The company was formerly known as AIkido Pharma Inc. and changed its name to Dominari Holdings Inc. in December 2022. Dominari Holdings Inc. was founded in 1967 and is headquartered in New York, New York.

Address